Registered nurse knowledge regarding noncytotoxic medication extravasation

0

The purpose of this study was to assess the knowledge level regarding noncytotoxic medications extravasation and its associated factors among staff nurses” Sisan et al (2018).

Abstract:

Extravasation and infiltration are among the most common intravenous therapy complications. For noncytotoxic agents, the incidence of extravasation remains unknown. There has been little research into extravasation due to ethical considerations limiting controlled research; most evidences are based on small, uncontrolled trials or case reports. The purpose of this study was to assess the knowledge level regarding noncytotoxic medications extravasation and its associated factors among staff nurses.A descriptive correlational design using self-administered questionnaire was employed. A convenience sample of 387 nurses completed a questionnaire about noncytotoxic medication extravasation. Statistical Package for Social Sciences version 21 was used to analyze data by applying the chi-square test, t test, and the Mann-Whitney test to assess the knowledge difference between open and closed units’ nurses.The results indicate that only 19.6% of nurses have a good knowledge about noncytotoxic medications extravasation. There was consistently poor staff knowledge regarding noncytotoxic medications extravasation. Although the closed units’ nurses reported relatively higher level of knowledge than open units’ nurses, their level of knowledge still inadequate. Health care organizations must consider developing specific policies regarding extravasation. Closed and open units’ nurses should be enrolled in special education programs to improve their level of knowledge regarding noncytotoxic medication extravasation.



Reference:

Sisan, M., Rayan, A., Elmorsy, S., Elyan, H. and Salahat, M. (2018) Knowledge regarding noncytotoxic medication extravasation among registered nurses working in western Saudi Arabia. Journal of Vascular Nursing. 36(1), p.12-22.

doi: 10.1016/j.jvn.2017.09.007.

Thank you to our partners for supporting IVTEAM

Share.

Comments are closed.